Dermavant Sciences Competitors, Revenue, Alternatives and Pricing

Claim your profile


Phoenix, AZ USA
Total Funding:N/A
Lead Investor(s):NovaQuest Capital Management

Estimated Revenue & Financials

  • Dermavant Sciences's estimated annual revenue is currently $9.1M per year.(?)
  • Dermavant Sciences received $100.0M in venture funding in August 2018.
  • Dermavant Sciences's estimated revenue per employee is $155,000

Employee Data

  • Dermavant Sciences has 59 Employees.(?)
  • Dermavant Sciences grew their employee count by 18% last year.
  • Dermavant Sciences currently has 2 job openings.

A Passion for Science and a Commitment to Dermatology Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients lives. The patient is at the heart of everything we do.